| Pharmaceutical active ingredients: |
| MetforminPioglitazone Hydrochloride |
| Available forms, composition and doses of Actoplus Met: |
| Tablets; Oral; Metformin 500 mg; Pioglitazone Hydrochloride 15 mgTablets; Oral; Metformin 500 mg; Pioglitazone Hydrochloride 30 mgTablets; Oral; Metformin 500 mg; Pioglitazone Hydrochloride 45 mgTablets; Oral; Metformin 850 mg; Pioglitazone Hydrochloride 15 mgTablets; Oral; Metformin 850 mg; Pioglitazone Hydrochloride 30 mgTablets; Oral; Metformin 850 mg; Pioglitazone Hydrochloride 45 mg |
| Actoplus Met medical category: |
| Human:Antidiabetic agentsBiguanidesThazolidinediones |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10BD05 - Metformin and Pioglitazone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Takeda Pharmaceutical |
| Related documents and information about Actoplus Met: |
| Actoplus Met prescribing information (PDF)Actoplus Met medication guide (PDF)Actoplus Met XR prescribing information (PDF) |